1-anilino-8-naphthalenesulfonate has been researched along with Diabetic Glomerulosclerosis in 12 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with diabetic nephropathy have increased plasma triglycerides and reduced activity of hepatic lipase (HL), which hydrolyzes triglycerides." | 1.33 | Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients. ( Baum, L; Chan, JC; Cheng, S; Lam, VK; Lindpaintner, K; Ng, MC; Poon, E; So, WY; Tomlinson, B; Wang, Y, 2005) |
| "Of the 39 patients with nondiabetic ESRD, 21 were undergoing CHT." | 1.28 | Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease. ( Goto, T; Hasegawa, H; Igaki, N; Miki, S; Oka, T; Sakurai, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Li, SL | 1 |
| Lin, W | 1 |
| Pan, RH | 1 |
| Dai, Y | 1 |
| Xia, YF | 1 |
| Fang, S | 1 |
| Cai, Y | 1 |
| Lyu, F | 1 |
| Zhang, H | 2 |
| Wu, C | 1 |
| Zeng, Y | 1 |
| Fan, C | 1 |
| Zou, S | 1 |
| Zhang, Y | 1 |
| Li, P | 2 |
| Wang, L | 1 |
| Guan, M | 1 |
| Zhao, H | 1 |
| Wang, Y | 2 |
| Zhao, T | 1 |
| Yan, M | 1 |
| Dong, X | 1 |
| Wang, Q | 1 |
| Li, J | 1 |
| Ma, L | 1 |
| Zheng, GS | 1 |
| Tan, YM | 1 |
| Shang, YY | 1 |
| Liu, YP | 1 |
| Hu, BA | 1 |
| Wang, D | 1 |
| Han, L | 1 |
| Wang, ZH | 1 |
| Zhang, W | 1 |
| Ti, Y | 1 |
| Zhong, M | 1 |
| Mori, J | 1 |
| Patel, VB | 1 |
| Ramprasath, T | 1 |
| Alrob, OA | 1 |
| DesAulniers, J | 1 |
| Scholey, JW | 1 |
| Lopaschuk, GD | 1 |
| Oudit, GY | 1 |
| Jain, S | 1 |
| De Petris, L | 1 |
| Hoshi, M | 1 |
| Akilesh, S | 1 |
| Chatterjee, R | 1 |
| Liapis, H | 1 |
| Secchi, A | 1 |
| Malaise, J | 1 |
| Caldara, R | 1 |
| Baum, L | 1 |
| Ng, MC | 1 |
| So, WY | 1 |
| Lam, VK | 1 |
| Poon, E | 1 |
| Tomlinson, B | 1 |
| Cheng, S | 1 |
| Lindpaintner, K | 1 |
| Chan, JC | 1 |
| Königsrainer, A | 1 |
| Föger, BH | 1 |
| Miesenbock, G | 1 |
| Patsch, JR | 1 |
| Margreiter, R | 1 |
| Fernández, JA | 1 |
| Claver, MA | 1 |
| Llorente, S | 1 |
| Gimeno, L | 1 |
| Robles, R | 1 |
| Ramírez, P | 1 |
| Bueno, FS | 1 |
| Rodríguez, JM | 1 |
| Luján, JA | 1 |
| Munítiz, V | 1 |
| Parrilla, P | 1 |
| Sakurai, T | 1 |
| Oka, T | 1 |
| Hasegawa, H | 1 |
| Igaki, N | 1 |
| Miki, S | 1 |
| Goto, T | 1 |
| DiMagno, EP | 1 |
| Hermon-Taylor, J | 1 |
| Go, VL | 1 |
| Lillehei, RC | 1 |
| Summerskill, WH | 1 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Metabolic results 3 years after simultaneous pancreas-kidney transplantation.
Topics: Amylases; Biomarkers; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetic Nephrop | 2005 |
11 other studies available for 1-anilino-8-naphthalenesulfonate and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Tripterygium glycoside tablet attenuates renal function impairment in diabetic nephropathy mice by regulating triglyceride metabolism.
Topics: Albumins; Animals; Cardiac Glycosides; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Glycos | 2022 |
Exendin-4 Improves Diabetic Kidney Disease in C57BL/6 Mice Independent of Brown Adipose Tissue Activation.
Topics: 3T3-L1 Cells; 8-Hydroxy-2'-Deoxyguanosine; Adenylate Kinase; Adipocytes, Brown; Adipogenesis; Adipos | 2020 |
Association between
Topics: Adult; Aged; Aged, 80 and over; Alleles; Asian People; Case-Control Studies; China; Diabetes Mellitu | 2020 |
CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy.
Topics: Animals; Apoptosis; Autophagy; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic | 2021 |
Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetic Nephropathies; Fibrosis; Forkhead | 2014 |
Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy.
Topics: Acute-Phase Proteins; Animals; Cell Line, Transformed; Diabetic Nephropathies; Dose-Response Relatio | 2011 |
Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients.
Topics: Apolipoprotein C-III; Apolipoproteins C; Case-Control Studies; Chin; Diabetes Mellitus, Type 2; Diab | 2005 |
Pancreas transplantation with systemic endocrine drainage leads to improvement in lipid metabolism.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitu | 1994 |
Clinical noninvasive evaluation of simultaneous pancreas-kidney transplants with the combined use of gammagraphy, Doppler ultrasound, and serum markers.
Topics: Amylases; Biomarkers; Biopsy; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Graft S | 2002 |
Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease.
Topics: Adult; Aged; Apoproteins; Arteriosclerosis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Femal | 1992 |
Functions of a pancreaticoduodenal allograft in man.
Topics: Acute Kidney Injury; Adult; Amino Acids; Amylases; Cholecystokinin; Diabetes Mellitus, Type 1; Diabe | 1971 |